KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Gross Margin (2016 - 2025)

Astrana Health (ASTH) has disclosed Gross Margin for 16 consecutive years, with 10.0% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 241.0% to 10.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 10.73% through Dec 2025, down 260.0% year-over-year, with the annual reading at 10.73% for FY2025, 261.0% down from the prior year.
  • Gross Margin hit 10.0% in Q4 2025 for Astrana Health, down from 10.17% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 35.07% in Q3 2021 to a low of 7.59% in Q4 2024.
  • Historically, Gross Margin has averaged 16.02% across 5 years, with a median of 14.9% in 2024.
  • Biggest five-year swings in Gross Margin: surged 747bps in 2021 and later tumbled -1102bps in 2022.
  • Year by year, Gross Margin stood at 11.92% in 2021, then increased by 17bps to 13.97% in 2022, then decreased by -21bps to 11.04% in 2023, then plummeted by -31bps to 7.59% in 2024, then skyrocketed by 32bps to 10.0% in 2025.
  • Business Quant data shows Gross Margin for ASTH at 10.0% in Q4 2025, 10.17% in Q3 2025, and 11.91% in Q2 2025.